119 related articles for article (PubMed ID: 33494648)
21. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
[TBL] [Abstract][Full Text] [Related]
22. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
[TBL] [Abstract][Full Text] [Related]
23. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
25. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
[TBL] [Abstract][Full Text] [Related]
26. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
28. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
[TBL] [Abstract][Full Text] [Related]
30. Altered presentation of oropharyngeal cancer, a 6-year review.
Floros P; Rao A; McCloy RA; Sim HW; Chin VT; Leavers BC; Crawford JA; Gallagher RM
ANZ J Surg; 2021 Jun; 91(6):1240-1245. PubMed ID: 33438358
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
[No Abstract] [Full Text] [Related]
33. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
[TBL] [Abstract][Full Text] [Related]
34. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
35. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
[TBL] [Abstract][Full Text] [Related]
36. Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma.
Broglie MA; Jochum W; Förbs D; Schönegg R; Stoeckli SJ
Cancer Cytopathol; 2015 Dec; 123(12):732-8. PubMed ID: 26348982
[TBL] [Abstract][Full Text] [Related]
37. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.
Martin-Gomez L; Fulp WJ; Schell MJ; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Lorincz A; Wenig B; Chung CH; Caudell JJ; Giuliano AR
Oral Oncol; 2019 May; 92():85-91. PubMed ID: 31010629
[TBL] [Abstract][Full Text] [Related]
38. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
[TBL] [Abstract][Full Text] [Related]
39. Machine Learning Prediction of Extracapsular Extension in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hatten KM; Amin J; Isaiah A
Otolaryngol Head Neck Surg; 2020 Nov; 163(5):992-999. PubMed ID: 32600154
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]